Sonidegib
Sonidegib
Sonidegib (pronounced soh-ni-deh-gib) is a medication used in the treatment of basal cell carcinoma, a type of skin cancer. It is classified as a hedgehog pathway inhibitor, which works by blocking signals that contribute to the growth of cancer cells.
Etymology
The name "Sonidegib" is derived from its chemical structure. The "soni-" prefix is an arbitrary designation, while "-degib" is a suffix used for hedgehog pathway inhibitors.
Usage
Sonidegib is used to treat adults with a type of skin cancer called basal cell carcinoma that has spread to other parts of the body (metastatic) or cannot be treated with surgery or radiation (locally advanced). It is taken orally, usually once a day.
Side Effects
Common side effects of Sonidegib include muscle spasms, hair loss, taste disturbance, fatigue, nausea, diarrhea, weight loss, and decreased appetite.
Related Terms
External links
- Medical encyclopedia article on Sonidegib
- Wikipedia's article - Sonidegib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski